Eastern Money Choice data shows that as of April 13, 28 listed companies in the medical device category have disclosed their 2022 annual reports, of which 18 companies have achieved year-on-year growth in net profit, accounting for 64.29%.

QuidelOrtho Corporation, a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced preliminary revenue results for the first quarter ended April 2, 2023.

CACLP 2023 is not just a platform for those 1,400 exhibitors to showcase their latest products and technologies, but also an opportunity for industry professionals to learn and network. CACLP 2023 will feature a wide range of new products, academic and enterprise activities to attract more than 30,000 visitors from all over the world.

Righton Gene announced on April 9 that in 2022, the company achieved operating revenue of CNY 424 million, up 45.83% year-on-year; attributable net profit of CNY 40,473,600, down 14.49% year-on-year; basic earnings per share of CNY 0.73.

The US Department of Health and Human Services' Biomedical Advanced Research Development Authority (BARDA) this week issued a solicitation for proposals for the research and development of immune assays to evaluate responses to COVID-19 vaccines.

​​Magtivio, a magnetic bead manufacturer from The Netherlands announces a distribution agreement with Premedical Lab from Beijing, China, a professional laboratory products distribution company in the life sciences arena.

According to Kalorama Information, the U.S. IVD market reached $53 billion in 2022, or approximately 40% to 45% of the global market. Projected growth is 2.4% annually on average through 2027.

The 8th China Experimental Medicine Conference (CEMC) is scheduled to be held at Primus Hotel Nanchang International Expo City on 27 May in 2023.

The 10th China IVD Industry Development Conference (CIIDC) is scheduled to be held at Primus Hotel Nanchang International Expo City from May 28 to 29 in 2023.

On March 21, according to the Qichacha data, the major shareholders of Shenzhen Thistory Bio-Medical Company have been changed from Shenzhen Thistory Bio-medical Management and Consulting Enterprise to Zybio Inc.